GLP‑1 receptor agonists (semaglutide: Wegovy®, Ozempic®) and dual GIP/GLP‑1 agents (tirzepatide: Mounjaro®) have transformed medical weight management. But these are prescription medicines with system...

Weight‑loss injections such as semaglutide (Wegovy®, Ozempic®) and the dual GIP/GLP‑1 agent tirzepatide (Mounjaro®) are prescription medicines. A growing black market, often sold via social media, non...

GLP‑1 medications such as Wegovy® and Ozempic® have helped many people lose significant weight and improve their health. Alongside this, social media has created a new scare term: “Ozempic Face.” The ...

Ashton Collins on BBC Breakfast: why we must restrict high‑risk cosmetic procedures Save Face director Ashton Collins speaks to BBC Breakfast about our three‑year campaign to restrict high‑risk cosmet...

The MHRA has issued updated safety warnings about iatrogenic botulism linked to botulinum toxin type A, against a backdrop of rising complaints about fake or unlicensed “Botox” being injected by non‑m...

Following the death of 33‑year‑old mother of five, Alice Webb, who died in 2024 after undergoing a liquid BBL with self‑styled “Lip King” Jordan Parke, the BBC has now revealed that Parke continued to...

Lip filler remains one of the most popular aesthetic treatments – and one of the most overdone. Social media trends such as “Russian lips” and extreme plumping have normalised results that are often u...

“Should I have Botox or filler?” is one of the most common questions people ask when they first consider aesthetic treatment. The two are often advertised together, but they do very different jobs – a...

Subscribe to our newsletter to receive the latest news & updates